Other Guidelines | Page 41 | European Cystic Fibrosis Society (ECFS)

Does Using Home Spirometry Lower Healthcare Costs of Care for people with cystic fibrosis?

Risk factors for joint inflammation and joint pain in cystic fibrosis

The effect of lumacaftor-ivacaftor on mucus clearance

Evaluating Pulmonary Exacerbation Treatment Differences in Women and Men with CF

Appearance and behaviour of methicillin resistant Staphylococcus aureus (MRSA) from early and chronic infection in cystic fibrosis (CF)

Liver toxicity with triple therapy in cystic fibrosis: when it is worth taking the risk.

Modeling the impact of antibiotic exposure on human microbiota

Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis

Effect of inhaled antibiotic therapy with levofloxacin in people with cystic fibrosis

Does having Exophiala in sputum samples make a difference to health in CF?

first
previous
…
37
38
39
40
41
42
43
44
45
…
next
last